Literature DB >> 8556475

Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytes.

L Vogel1, L van Alphen, F Geluk, A Troelstra, E Martin, R Bredius, P Eijk, H Jansen, J Dankert.   

Abstract

Since nonencapsulated Haemophilus influenzae persists in the lower respiratory tracts of patients with chronic bronchitis despite the presence of specific antibodies, complement, and polymorphonuclear leukocytes (PMNs), opsonophagocytosis of H. influenzae was analyzed. Nonencapsulated H. influenzae isolated from the sputa of chronic bronchitis patients was labeled with fluorescein isothiocyanate and incubated with human PMNs in the presence of complement and antibodies for 30 min at 37 degrees C. Candida albicans was added to each sample as an internal standard, and the reduction of the number of bacteria was determined by flow cytometry. Fluorescence quenching with ethidium bromide was used to discriminate between intracellular and extracellular bacteria. Opsonophagocytosis of viable H. influenzae d1 was 17% +/- 29% in the presence of complement and human pooled sera containing high titers of strain-specific antibodies. Opsonophagocytosis of six other H. influenzae strains was also poor. Under the same conditions, opsonophagocytosis of Staphylococcus aureus was 90% +/- 5%, and opsonophagocytosis of C. albicans was 55% +/- 23%. About half of the number of H. influenzae bacteria associated with PMNs was internalized. Opsonophagocytosis of heat-killed H. influenzae d1 (41% +/- 20%) was higher than that of viable bacteria of the same strain (P < 0.05). This result suggests that the accessibility of epitopes on H. influenzae for opsonizing antibodies is better on killed than on viable bacteria. We conclude that viable nonencapsulated H. influenzae is poorly opsonophagocytized in the presence of strain-specific antibodies and complement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556475      PMCID: PMC368274          DOI: 10.1128/cdli.1.4.394-400.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  28 in total

1.  Purification and cryopreservation of phagocytes from human blood.

Authors:  D Roos; M de Boer
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

2.  The pathogenicity of Haemophilus influenzae.

Authors:  D C Turk
Journal:  J Med Microbiol       Date:  1984-08       Impact factor: 2.472

3.  Phagocytosis of bacteria by human leukocytes measured by flow cytometry.

Authors:  C F Bassøe; O D Laerum; C O Solberg; B Haneberg
Journal:  Proc Soc Exp Biol Med       Date:  1983-11

4.  Flow cytometric assay for combined measurement of phagocytosis and intracellular killing of Candida albicans.

Authors:  R Bjerknes
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

5.  Human serum activities against Hemophilus influenzae, type b.

Authors:  P Anderson; R B Johnston; D H Smith
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

6.  Monoclonal antibodies directed against a cell surface-exposed outer membrane protein of Haemophilus influenzae type b.

Authors:  S M Robertson; C F Frisch; P A Gulig; J R Kettman; K H Johnston; E J Hansen
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  Antigenic heterogeneity of outer membrane proteins of nontypable Haemophilus influenzae is a basis for a serotyping system.

Authors:  T F Murphy; M A Apicella
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Immunologic studies in patients with recurrent bronchopulmonary infections.

Authors:  E Kagan; C L Soskolne; S Zwi; S Hurwitz; G M Maier; T Ipp; A R Rabson
Journal:  Am Rev Respir Dis       Date:  1975-04

9.  Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies.

Authors:  B Akerström; T Brodin; K Reis; L Björck
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  Opsonic antibodies to outer membrane protein P2 of nonencapsulated Haemophilus influenza are strain specific.

Authors:  A Troelstra; L Vogel; L van Alphen; P Eijk; H Jansen; J Dankert
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more
  5 in total

1.  Amoxicillin treatment of experimental acute otitis media caused by Haemophilus influenzae with non-beta-lactamase-mediated resistance to beta-lactams: aspects of virulence and treatment.

Authors:  A Melhus; H Janson; E Westman; A Hermansson; A Forsgren; K Prellner
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae.

Authors:  B Duim; L Vogel; W Puijk; H M Jansen; R H Meloen; J Dankert; L van Alphen
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Immune selection for antigenic drift of major outer membrane protein P2 of Haemophilus influenzae during persistence in subcutaneous tissue cages in rabbits.

Authors:  L Vogel; B Duim; F Geluk; P Eijk; H Jansen; J Dankert; L vanAlphen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

4.  Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication.

Authors:  L van Alphen; P Eijk; H Käyhty; J van Marle; J Dankert
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

5.  Identification of Haemophilus influenzae clones associated with invasive disease a decade after introduction of H. influenzae serotype b vaccination in Italy.

Authors:  Maria Giufrè; Rita Cardines; Marisa Accogli; Manuela Pardini; Marina Cerquetti
Journal:  Clin Vaccine Immunol       Date:  2013-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.